Signaturefd LLC Grows Position in Axon Enterprise, Inc. (NASDAQ:AXON)

Signaturefd LLC increased its holdings in Axon Enterprise, Inc. (NASDAQ:AXONFree Report) by 16.3% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 655 shares of the biotechnology company’s stock after acquiring an additional 92 shares during the quarter. Signaturefd LLC’s holdings in Axon Enterprise were worth $262,000 as of its most recent SEC filing.

A number of other hedge funds also recently added to or reduced their stakes in the business. Sequoia Financial Advisors LLC lifted its stake in Axon Enterprise by 4.9% in the third quarter. Sequoia Financial Advisors LLC now owns 1,727 shares of the biotechnology company’s stock worth $690,000 after acquiring an additional 81 shares during the period. Argus Investors Counsel Inc. lifted its stake in Axon Enterprise by 1.1% in the third quarter. Argus Investors Counsel Inc. now owns 4,543 shares of the biotechnology company’s stock worth $1,816,000 after acquiring an additional 51 shares during the period. Foundations Investment Advisors LLC purchased a new stake in Axon Enterprise in the third quarter worth about $221,000. Whittier Trust Co. of Nevada Inc. lifted its stake in Axon Enterprise by 3.8% in the third quarter. Whittier Trust Co. of Nevada Inc. now owns 8,290 shares of the biotechnology company’s stock worth $3,312,000 after acquiring an additional 301 shares during the period. Finally, Whittier Trust Co. lifted its position in shares of Axon Enterprise by 5.0% during the third quarter. Whittier Trust Co. now owns 15,820 shares of the biotechnology company’s stock valued at $6,321,000 after buying an additional 756 shares during the last quarter. 79.08% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several analysts have commented on AXON shares. Bank of America started coverage on shares of Axon Enterprise in a research report on Wednesday, July 17th. They set a “buy” rating and a $380.00 price target for the company. JMP Securities increased their price target on shares of Axon Enterprise from $375.00 to $430.00 and gave the company an “outperform” rating in a research report on Thursday, September 12th. Robert W. Baird increased their price target on shares of Axon Enterprise from $360.00 to $400.00 and gave the company an “outperform” rating in a research report on Tuesday, September 10th. Northland Securities increased their price target on shares of Axon Enterprise from $330.00 to $365.00 and gave the company an “outperform” rating in a research report on Thursday, August 8th. Finally, The Goldman Sachs Group increased their price target on shares of Axon Enterprise from $385.00 to $441.00 and gave the company a “buy” rating in a research report on Wednesday. Two equities research analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company’s stock. According to MarketBeat.com, Axon Enterprise currently has a consensus rating of “Moderate Buy” and a consensus target price of $382.85.

Check Out Our Latest Research Report on Axon Enterprise

Insider Buying and Selling

In related news, Director Matthew R. Mcbrady sold 2,000 shares of the stock in a transaction that occurred on Friday, August 9th. The shares were sold at an average price of $364.66, for a total value of $729,320.00. Following the transaction, the director now owns 4,892 shares in the company, valued at approximately $1,783,916.72. This represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. In related news, Director Matthew R. Mcbrady sold 2,000 shares of the stock in a transaction that occurred on Friday, August 9th. The shares were sold at an average price of $364.66, for a total value of $729,320.00. Following the transaction, the director now owns 4,892 shares in the company, valued at approximately $1,783,916.72. This represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Patrick W. Smith sold 80,300 shares of the stock in a transaction that occurred on Friday, August 23rd. The stock was sold at an average price of $371.78, for a total transaction of $29,853,934.00. Following the completion of the transaction, the chief executive officer now owns 3,015,366 shares in the company, valued at approximately $1,121,052,771.48. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 371,172 shares of company stock worth $137,000,162. 6.10% of the stock is owned by company insiders.

Axon Enterprise Price Performance

Shares of NASDAQ:AXON opened at $444.52 on Friday. Axon Enterprise, Inc. has a twelve month low of $199.29 and a twelve month high of $455.17. The company’s 50 day moving average is $396.09 and its 200 day moving average is $336.52. The company has a current ratio of 2.88, a quick ratio of 2.52 and a debt-to-equity ratio of 0.35. The company has a market cap of $33.55 billion, a PE ratio of 129.98, a price-to-earnings-growth ratio of 12.05 and a beta of 0.94.

Axon Enterprise (NASDAQ:AXONGet Free Report) last issued its quarterly earnings results on Tuesday, August 6th. The biotechnology company reported $1.20 earnings per share for the quarter, topping the consensus estimate of $1.02 by $0.18. Axon Enterprise had a net margin of 16.06% and a return on equity of 9.34%. The company had revenue of $504.00 million for the quarter, compared to the consensus estimate of $478.35 million. During the same quarter in the prior year, the company earned $0.80 EPS. Axon Enterprise’s quarterly revenue was up 34.5% on a year-over-year basis. On average, sell-side analysts forecast that Axon Enterprise, Inc. will post 1.79 EPS for the current year.

Axon Enterprise Profile

(Free Report)

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.

Featured Articles

Institutional Ownership by Quarter for Axon Enterprise (NASDAQ:AXON)

Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.